{
    "organizations": [],
    "uuid": "38653b77d465f679c637c5045b92083c9ec6089a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gensight-announces-publication-of/brief-gensight-announces-publication-of-positive-data-from-phase-i-ii-trial-of-gs010-idUSFWN1Q90J6",
    "ord_in_thread": 0,
    "title": "BRIEF-Gensight Announces Publication Of Positive Data From Phase I/II Trial Of Gs010",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - GENSIGHT BIOLOGICS SA:\n* GENSIGHT BIOLOGICS ANNOUNCES PUBLICATION OF POSITIVE DATA FROM PHASE I/II TRIAL AND LONG-TERM FOLLOW-UP OF GS010 IN OPHTHALMOLOGY, THE JOURNAL OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY\n* GS010 CONFIRMED AS SAFE AND WELL TOLERATED 2 YEARS AFTER A SINGLE UNILATERAL INTRAVITREAL INJECTION\n* SUSTAINED IMPROVEMENT OF VISUAL ACUITY AT 2 YEARS OF FOLLOW-UP IN LHON SUBJECTS WITH LESS THAN 2 YEARS OF VISUAL LOSS PRIOR TO TREATMENT\n* GS010 (RAAV2/2-ND4) IS SAFE AND WELL TOLERATED 2 YEARS AFTER A SINGLE UNILATERAL INTRAVITREAL ADMINISTRATION. Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-20T14:38:00.000+02:00",
    "crawled": "2018-02-21T21:21:17.089+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "gensight",
        "biologics",
        "sa",
        "gensight",
        "biologics",
        "announces",
        "publication",
        "positive",
        "data",
        "phase",
        "trial",
        "gs010",
        "ophthalmology",
        "journal",
        "american",
        "academy",
        "ophthalmology",
        "gs010",
        "confirmed",
        "safe",
        "well",
        "tolerated",
        "year",
        "single",
        "unilateral",
        "intravitreal",
        "injection",
        "sustained",
        "improvement",
        "visual",
        "acuity",
        "year",
        "lhon",
        "subject",
        "less",
        "year",
        "visual",
        "loss",
        "prior",
        "treatment",
        "gs010",
        "safe",
        "well",
        "tolerated",
        "year",
        "single",
        "unilateral",
        "intravitreal",
        "administration",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}